United States Indapamide Market Report 2017

May 2014 | 114 pages | ID: UAF30F30EE6EN
QYResearch

Abstracts

In this report, the United States Indapamide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Indapamide in these regions, from 2012 to 2022 (forecast).

United States Indapamide market competition by top manufacturers/players, with Indapamide sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Servier
• Cigna
• ANI Pharma
• Mylan
• Teva
• Shandong Yinfeida Pharmaceutical
• Taj Pharmaceuticals
• Supra Chemicals
• Glenmark Pharmaceuticals
• Suzhou Lixinpharm
• Lisheng Pharma
• Apeloa Kangyu

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• 1.25 mg Indapamide Tablets
• 2.5 mg Indapamide Tablets

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Indapamide for each application, including

• High Blood Pressure Treatment
• Diuretic
• Hypertension Treatment

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Indapamide Market Report 2017

1 INDAPAMIDE OVERVIEW

1.1 Product Overview and Scope of Indapamide
1.2 Classification of Indapamide by Product Category
  1.2.1 United States Indapamide Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Indapamide Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 1.25 mg Indapamide Tablets
  1.2.4 2.5 mg Indapamide Tablets
1.3 United States Indapamide Market by Application/End Users
  1.3.1 United States Indapamide Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 High Blood Pressure Treatment
  1.3.3 Diuretic
  1.3.4 Hypertension Treatment
1.4 United States Indapamide Market by Region
  1.4.1 United States Indapamide Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Indapamide Status and Prospect (2012-2022)
  1.4.3 Southwest Indapamide Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Indapamide Status and Prospect (2012-2022)
  1.4.5 New England Indapamide Status and Prospect (2012-2022)
  1.4.6 The South Indapamide Status and Prospect (2012-2022)
  1.4.7 The Midwest Indapamide Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Indapamide (2012-2022)
  1.5.1 United States Indapamide Sales and Growth Rate (2012-2022)
  1.5.2 United States Indapamide Revenue and Growth Rate (2012-2022)

2 UNITED STATES INDAPAMIDE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Indapamide Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Indapamide Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Indapamide Average Price by Players/Suppliers (2012-2017)
2.4 United States Indapamide Market Competitive Situation and Trends
  2.4.1 United States Indapamide Market Concentration Rate
  2.4.2 United States Indapamide Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Indapamide Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INDAPAMIDE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Indapamide Sales and Market Share by Region (2012-2017)
3.2 United States Indapamide Revenue and Market Share by Region (2012-2017)
3.3 United States Indapamide Price by Region (2012-2017)

4 UNITED STATES INDAPAMIDE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Indapamide Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Indapamide Revenue and Market Share by Type (2012-2017)
4.3 United States Indapamide Price by Type (2012-2017)
4.4 United States Indapamide Sales Growth Rate by Type (2012-2017)

5 UNITED STATES INDAPAMIDE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Indapamide Sales and Market Share by Application (2012-2017)
5.2 United States Indapamide Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES INDAPAMIDE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Servier
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Indapamide Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Servier Indapamide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Cigna
  6.2.2 Indapamide Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cigna Indapamide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 ANI Pharma
  6.3.2 Indapamide Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 ANI Pharma Indapamide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Mylan
  6.4.2 Indapamide Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Mylan Indapamide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Teva
  6.5.2 Indapamide Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Teva Indapamide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shandong Yinfeida Pharmaceutical
  6.6.2 Indapamide Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Shandong Yinfeida Pharmaceutical Indapamide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Taj Pharmaceuticals
  6.7.2 Indapamide Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Taj Pharmaceuticals Indapamide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Supra Chemicals
  6.8.2 Indapamide Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Supra Chemicals Indapamide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Glenmark Pharmaceuticals
  6.9.2 Indapamide Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Glenmark Pharmaceuticals Indapamide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Suzhou Lixinpharm
  6.10.2 Indapamide Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Suzhou Lixinpharm Indapamide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Lisheng Pharma
6.12 Apeloa Kangyu

7 INDAPAMIDE MANUFACTURING COST ANALYSIS

7.1 Indapamide Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Indapamide

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Indapamide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Indapamide Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INDAPAMIDE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Indapamide Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Indapamide Sales Volume Forecast by Type (2017-2022)
11.3 United States Indapamide Sales Volume Forecast by Application (2017-2022)
11.4 United States Indapamide Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Indapamide
Figure United States Indapamide Market Size (K Pcs) by Type (2012-2022)
Figure United States Indapamide Sales Volume Market Share by Type (Product Category) in 2016
Figure 1.25 mg Indapamide Tablets Product Picture
Figure 2.5 mg Indapamide Tablets Product Picture
Figure United States Indapamide Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Indapamide by Application in 2016
Figure High Blood Pressure Treatment Examples
Figure Diuretic Examples
Figure Hypertension Treatment Examples
Figure United States Indapamide Market Size (Million USD) by Region (2012-2022)
Figure The West Indapamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Indapamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Indapamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Indapamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Indapamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Indapamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Indapamide Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Indapamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Indapamide Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Indapamide Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Indapamide Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Indapamide Sales Share by Players/Suppliers
Figure 2017 United States Indapamide Sales Share by Players/Suppliers
Figure United States Indapamide Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Indapamide Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Indapamide Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Indapamide Revenue Share by Players/Suppliers
Figure 2017 United States Indapamide Revenue Share by Players/Suppliers
Table United States Market Indapamide Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Indapamide Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Indapamide Market Share of Top 3 Players/Suppliers
Figure United States Indapamide Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Indapamide Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Indapamide Product Category
Table United States Indapamide Sales (K Pcs) by Region (2012-2017)
Table United States Indapamide Sales Share by Region (2012-2017)
Figure United States Indapamide Sales Share by Region (2012-2017)
Figure United States Indapamide Sales Market Share by Region in 2016
Table United States Indapamide Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Indapamide Revenue Share by Region (2012-2017)
Figure United States Indapamide Revenue Market Share by Region (2012-2017)
Figure United States Indapamide Revenue Market Share by Region in 2016
Table United States Indapamide Price (USD/Pcs) by Region (2012-2017)
Table United States Indapamide Sales (K Pcs) by Type (2012-2017)
Table United States Indapamide Sales Share by Type (2012-2017)
Figure United States Indapamide Sales Share by Type (2012-2017)
Figure United States Indapamide Sales Market Share by Type in 2016
Table United States Indapamide Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Indapamide Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Indapamide by Type (2012-2017)
Figure Revenue Market Share of Indapamide by Type in 2016
Table United States Indapamide Price (USD/Pcs) by Types (2012-2017)
Figure United States Indapamide Sales Growth Rate by Type (2012-2017)
Table United States Indapamide Sales (K Pcs) by Application (2012-2017)
Table United States Indapamide Sales Market Share by Application (2012-2017)
Figure United States Indapamide Sales Market Share by Application (2012-2017)
Figure United States Indapamide Sales Market Share by Application in 2016
Table United States Indapamide Sales Growth Rate by Application (2012-2017)
Figure United States Indapamide Sales Growth Rate by Application (2012-2017)
Table Servier Basic Information List
Table Servier Indapamide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Servier Indapamide Sales Growth Rate (2012-2017)
Figure Servier Indapamide Sales Market Share in United States (2012-2017)
Figure Servier Indapamide Revenue Market Share in United States (2012-2017)
Table Cigna Basic Information List
Table Cigna Indapamide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cigna Indapamide Sales Growth Rate (2012-2017)
Figure Cigna Indapamide Sales Market Share in United States (2012-2017)
Figure Cigna Indapamide Revenue Market Share in United States (2012-2017)
Table ANI Pharma Basic Information List
Table ANI Pharma Indapamide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ANI Pharma Indapamide Sales Growth Rate (2012-2017)
Figure ANI Pharma Indapamide Sales Market Share in United States (2012-2017)
Figure ANI Pharma Indapamide Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Indapamide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mylan Indapamide Sales Growth Rate (2012-2017)
Figure Mylan Indapamide Sales Market Share in United States (2012-2017)
Figure Mylan Indapamide Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Indapamide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Indapamide Sales Growth Rate (2012-2017)
Figure Teva Indapamide Sales Market Share in United States (2012-2017)
Figure Teva Indapamide Revenue Market Share in United States (2012-2017)
Table Shandong Yinfeida Pharmaceutical Basic Information List
Table Shandong Yinfeida Pharmaceutical Indapamide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shandong Yinfeida Pharmaceutical Indapamide Sales Growth Rate (2012-2017)
Figure Shandong Yinfeida Pharmaceutical Indapamide Sales Market Share in United States (2012-2017)
Figure Shandong Yinfeida Pharmaceutical Indapamide Revenue Market Share in United States (2012-2017)
Table Taj Pharmaceuticals Basic Information List
Table Taj Pharmaceuticals Indapamide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Taj Pharmaceuticals Indapamide Sales Growth Rate (2012-2017)
Figure Taj Pharmaceuticals Indapamide Sales Market Share in United States (2012-2017)
Figure Taj Pharmaceuticals Indapamide Revenue Market Share in United States (2012-2017)
Table Supra Chemicals Basic Information List
Table Supra Chemicals Indapamide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Supra Chemicals Indapamide Sales Growth Rate (2012-2017)
Figure Supra Chemicals Indapamide Sales Market Share in United States (2012-2017)
Figure Supra Chemicals Indapamide Revenue Market Share in United States (2012-2017)
Table Glenmark Pharmaceuticals Basic Information List
Table Glenmark Pharmaceuticals Indapamide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Glenmark Pharmaceuticals Indapamide Sales Growth Rate (2012-2017)
Figure Glenmark Pharmaceuticals Indapamide Sales Market Share in United States (2012-2017)
Figure Glenmark Pharmaceuticals Indapamide Revenue Market Share in United States (2012-2017)
Table Suzhou Lixinpharm Basic Information List
Table Suzhou Lixinpharm Indapamide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Suzhou Lixinpharm Indapamide Sales Growth Rate (2012-2017)
Figure Suzhou Lixinpharm Indapamide Sales Market Share in United States (2012-2017)
Figure Suzhou Lixinpharm Indapamide Revenue Market Share in United States (2012-2017)
Table Lisheng Pharma Basic Information List
Table Apeloa Kangyu Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Indapamide
Figure Manufacturing Process Analysis of Indapamide
Figure Indapamide Industrial Chain Analysis
Table Raw Materials Sources of Indapamide Major Players/Suppliers in 2016
Table Major Buyers of Indapamide
Table Distributors/Traders List
Figure United States Indapamide Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Indapamide Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Indapamide Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Indapamide Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Indapamide Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Indapamide Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Indapamide Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Indapamide Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Indapamide Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Indapamide Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Indapamide Sales Volume Share Forecast by Region (2017-2022)
Figure United States Indapamide Sales Volume Share Forecast by Region (2017-2022)
Figure United States Indapamide Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources